178 related articles for article (PubMed ID: 15167569)
1. Cannabinoid agonist-induced sensitisation to morphine place preference in mice.
Manzanedo C; Aguilar MA; Rodríguez-Arias M; Navarro M; Miñarro J
Neuroreport; 2004 Jun; 15(8):1373-7. PubMed ID: 15167569
[TBL] [Abstract][Full Text] [Related]
2. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
[TBL] [Abstract][Full Text] [Related]
3. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.
Chaperon F; Soubrié P; Puech AJ; Thiébot MH
Psychopharmacology (Berl); 1998 Feb; 135(4):324-32. PubMed ID: 9539255
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
[TBL] [Abstract][Full Text] [Related]
5. Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.
Castañé A; Maldonado R; Valverde O
Br J Pharmacol; 2004 Aug; 142(8):1309-17. PubMed ID: 15265804
[TBL] [Abstract][Full Text] [Related]
6. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation.
Vlachou S; Nomikos GG; Panagis G
Behav Brain Res; 2003 May; 141(2):215-22. PubMed ID: 12742258
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.
Hruba L; McMahon LR
Eur J Pharmacol; 2014 Mar; 727():35-42. PubMed ID: 24486701
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Trezza V; Vanderschuren LJ
Psychopharmacology (Berl); 2008 Apr; 197(2):217-27. PubMed ID: 18058088
[TBL] [Abstract][Full Text] [Related]
12. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
Ahmad T; Sun N; Lyons D; Laviolette SR
Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.
Pandolfo P; Vendruscolo LF; Sordi R; Takahashi RN
Psychopharmacology (Berl); 2009 Aug; 205(2):319-26. PubMed ID: 19407992
[TBL] [Abstract][Full Text] [Related]
14. Modulatory role of the intra-accumbal CB1 receptor in protein level of the c-fos and pCREB/CREB ratio in the nucleus accumbens and ventral tegmental area in extinction and morphine seeking in the rats.
Khaleghzadeh-Ahangar H; Khodagholi F; Shaerzadeh F; Haghparast A
Brain Res Bull; 2018 Sep; 142():320-327. PubMed ID: 30170186
[TBL] [Abstract][Full Text] [Related]
15. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
16. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
18. Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference.
Karimi S; Azizi P; Shamsizadeh A; Haghparast A
Behav Brain Res; 2013 Jun; 247():125-31. PubMed ID: 23523958
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
Burgos E; Pascual D; Martín MI; Goicoechea C
Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor modulation changes the accumbal neuronal responses to morphine in the reinstatement of morphine-induced conditioned place preference.
Khaleghzadeh-Ahangar H; Haghparast A
Addict Biol; 2020 Nov; 25(6):e12817. PubMed ID: 31436887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
